SCHEMBL6706537

SCHEMBL6706537

CCOC(=O)c1cccc(N2CCN(C(=O)OCc3ccccc3)CC2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 12/20 0.54
SIGMAR1 Q99720 12/20 0.54
HRH2 P25021 3/20 0.54
HRH1 P35367 3/20 0.54
HRH3 Q9Y5N1 2/20 0.54
HTR1A P08908 2/20 0.54
HTR1B P28222 2/20 0.54
HTR2A P28223 2/20 0.54
HTR2C P28335 2/20 0.54
HTR1E P28566 2/20 0.54
HTR2B P41595 2/20 0.54
ADRA2A P08913 1/20 0.54
ADRA2B P18089 1/20 0.54
ADRA2C P18825 1/20 0.54
DRD1 P21728 1/20 0.54
SLC6A4 P31645 1/20 0.54
SLC6A2 P23975 2/20 0.53
CHRM1 P11229 1/20 0.53
ALDH1A1 P00352 4/20 0.53
MAPT P10636 5/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13006300 0.87 TMEM97 (0.57) TMEM97SIGMAR1HRH2HRH1HRH3
SCHEMBL31466702 0.87 TMEM97 (0.53) TMEM97SIGMAR1HRH2HRH1HRH3
SCHEMBL6011450 0.85 ALDH1A1 (0.56) ALDH1A1MAPTLMNAGAAHTT
SCHEMBL12251448 0.84 TMEM97 (0.56) TMEM97SIGMAR1HRH2HRH1HRH3
SCHEMBL22290980 0.83 LMNA (0.57) TMEM97SIGMAR1HRH2HRH1HRH3
SCHEMBL6707329 0.83 PRMT1 (0.67) HTR1AALDH1A1MAPTLMNAHPGD
SCHEMBL2384619 0.82 DRD2 (0.59) TMEM97SIGMAR1HRH2HRH1HRH3
SCHEMBL28078043 0.82 PRMT1 (0.58) HTR1ALMNAMAPK1
SCHEMBL674604 0.82 GPR119 (0.56) ALDH1A1MAPTLMNAKDM4EGAA
Iodide SCHEMBL6706501 0.82 PRMT1 (0.66) HTR1AALDH1A1MAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1738805-A N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as CGRP-antagonists for treating a headache BOEHRINGER INGELHEIM INT (DE) 2006-02-22 CN disclosed
US-20040192729-A1 Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192729-A1 Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereof NPY1R, ADCY1, SRD5A1 TMEM97 1927/4885SIGMAR1 319/4885HRH2 370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.